| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $96.5M | -52.3% |
| Cost of Revenue | $42.1M | -51.1% |
| R&D Expense | $14.4M | +3.3% |
| SG&A Expense | $22.3M | +23.0% |
| Operating Income | -$86.6M | -1161.6% |
| Pre-tax Income | -$86.4M | -1468.8% |
| Income Tax | $3.5M | +231.0% |
| Net Income | -$89.8M | -1079.9% |
| EPS (Basic) | -$3.48 | -1041.1% |
| EPS (Diluted) | -$3.48 | -1086.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.2M | -71.4% |
| Accounts Receivable | $16.2M | -32.8% |
| Inventory | $1.7M | -39.8% |
| Current Assets | $52.9M | -18.6% |
| Total Assets | $98.5M | +0.3% |
| Current Liabilities | $80.1M | +81.4% |
| Total Liabilities | $94.7M | +61.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.2M | -1118.8% |
| Investing Cash Flow | -$3.9M | -468.1% |
| Financing Cash Flow | $46.2M | +398.8% |
| Stockholders' Equity |
| $3.9M |
| -90.3% |